Search research articles
Contact Us
Filters
Showing results (61-70 of 166) with videos related to
Page
of 17
Sort By:
Cancer Cell
|
December 13, 2017
mTORC2 Promotes Tumorigenesis via Lipid Synthesis
Yakir Guri, Marco Colombi, Eva Dazert, et al.
Frontiers in Oncology
|
March 1, 2021
iNOS Associates With Poor Survival in Melanoma: A Role for Nitric Oxide in the PI3K-AKT Pathway Stimulation and PTEN S-Nitrosylation
Zhen Ding, Dai Ogata, Jason Roszik, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 6, 2017
Phase Ib/II Study of the Safety and Efficacy of Combination Therapy with Multikinase VEGF Inhibitor Pazopanib and MEK Inhibitor Trametinib In Advanced Soft Tissue Sarcoma
Vivek Subbiah, Christian Meyer, Ralph Zinner, et al.
Pigment Cell & Melanoma Research
|
April 19, 2016
Comparative analysis of the GNAQ, GNA11, SF3B1, and EIF1AX driver mutations in melanoma and across the cancer spectrum
Douglas B Johnson, Jason Roszik, Alexander N Shoushtari, et al.
Cancer Immunology Research
|
October 5, 2016
IL2 Variant Circumvents ICOS+ Regulatory T-cell Expansion and Promotes NK Cell Activation
Geok Choo Sim, Chengwen Liu, Ena Wang, et al.
Biorxiv : the Preprint Server for Biology
|
March 10, 2025
IL-1R1 Blockade Boosts CD40 Agonist Immune Responses but Fails to Improve Efficacy or Reduce Hepatotoxicity in Pancreatic Cancer
Akash Boda, Irfan N Bandey, Saikat Chowdhury, et al.
Cancer Immunology, Immunotherapy : CII
|
September 14, 2019
Lymphocyte-specific kinase expression is a prognostic indicator in ovarian cancer and correlates with a prominent B cell transcriptional signature
Emily Hinchcliff, Cherie Paquette, Jason Roszik, et al.
Cancer Research Communications
|
August 2, 2023
Inhibition of Microsomal Prostaglandin E2 Synthase Reduces Collagen Deposition in Melanoma Tumors and May Improve Immunotherapy Efficacy by Reducing T-cell Exhaustion
Yasunari Fukuda, Sun-Hee Kim, Matias A Bustos, et al.
Clinical Sarcoma Research
|
June 21, 2017
Overexpressed PRAME is a potential immunotherapy target in sarcoma subtypes
Jason Roszik, Wei-Lien Wang, John A Livingston, et al.
Pigment Cell & Melanoma Research
|
January 24, 2016
Microsomal PGE2 synthase-1 regulates melanoma cell survival and associates with melanoma disease progression
Sun-Hee Kim, Yuuri Hashimoto, Sung-Nam Cho, et al.
Page
of 17
Search research articles
Search
Showing results (61-70 of 166) with videos related to
Sort By:
Page
of 17
Cancer Cell
|
December 13, 2017
mTORC2 Promotes Tumorigenesis via Lipid Synthesis
Yakir Guri, Marco Colombi, Eva Dazert, et al.
Frontiers in Oncology
|
March 1, 2021
iNOS Associates With Poor Survival in Melanoma: A Role for Nitric Oxide in the PI3K-AKT Pathway Stimulation and PTEN S-Nitrosylation
Zhen Ding, Dai Ogata, Jason Roszik, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 6, 2017
Phase Ib/II Study of the Safety and Efficacy of Combination Therapy with Multikinase VEGF Inhibitor Pazopanib and MEK Inhibitor Trametinib In Advanced Soft Tissue Sarcoma
Vivek Subbiah, Christian Meyer, Ralph Zinner, et al.
Pigment Cell & Melanoma Research
|
April 19, 2016
Comparative analysis of the GNAQ, GNA11, SF3B1, and EIF1AX driver mutations in melanoma and across the cancer spectrum
Douglas B Johnson, Jason Roszik, Alexander N Shoushtari, et al.
Cancer Immunology Research
|
October 5, 2016
IL2 Variant Circumvents ICOS+ Regulatory T-cell Expansion and Promotes NK Cell Activation
Geok Choo Sim, Chengwen Liu, Ena Wang, et al.
Biorxiv : the Preprint Server for Biology
|
March 10, 2025
IL-1R1 Blockade Boosts CD40 Agonist Immune Responses but Fails to Improve Efficacy or Reduce Hepatotoxicity in Pancreatic Cancer
Akash Boda, Irfan N Bandey, Saikat Chowdhury, et al.
Cancer Immunology, Immunotherapy : CII
|
September 14, 2019
Lymphocyte-specific kinase expression is a prognostic indicator in ovarian cancer and correlates with a prominent B cell transcriptional signature
Emily Hinchcliff, Cherie Paquette, Jason Roszik, et al.
Cancer Research Communications
|
August 2, 2023
Inhibition of Microsomal Prostaglandin E2 Synthase Reduces Collagen Deposition in Melanoma Tumors and May Improve Immunotherapy Efficacy by Reducing T-cell Exhaustion
Yasunari Fukuda, Sun-Hee Kim, Matias A Bustos, et al.
Clinical Sarcoma Research
|
June 21, 2017
Overexpressed PRAME is a potential immunotherapy target in sarcoma subtypes
Jason Roszik, Wei-Lien Wang, John A Livingston, et al.
Pigment Cell & Melanoma Research
|
January 24, 2016
Microsomal PGE2 synthase-1 regulates melanoma cell survival and associates with melanoma disease progression
Sun-Hee Kim, Yuuri Hashimoto, Sung-Nam Cho, et al.
Page
of 17